Click for best price
Bronchiectasis Drugs Market Size, Share 2023
The global Bronchiectasis Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Diagnosis methods of bacterial lung infections have several limitations, including failure to precisely recognize the cause of infection and inability to provide a full representation of the bacterial load present in the lungs. This has driven researchers to develop a new probe, which can detect bacteria in the lungs efficiently.
This report aims to provide a comprehensive presentation of the global market for Bronchiectasis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bronchiectasis Drugs. This report contains market size and forecasts of Bronchiectasis Drugs in global, including the following market information:
Global Bronchiectasis Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The use of this probe will also help in identifying the exact causing agent of bronchiectasis. The high-resolution computed tomography (HRCT) scan has also emerged as a popular diagnostic technique for screening bronchiectasis and other respiratory diseases. Such advances in the diagnostics of respiratory diseases will enable pulmonologists and otolaryngologists to precisely identify the stage of the disease and provide appropriate and timely treatment to patients.
We surveyed the Bronchiectasis Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bronchiectasis Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Bronchiectasis Drugs Market Segment Percentages, by Type, 2022 (%)
- Antibiotics
- Expectorants
- Other drugs
Global Bronchiectasis Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Bronchiectasis Drugs Market Segment Percentages, by Application, 2022 (%)
- Hospital
- Research institute
- Clinic
- Other
Global Bronchiectasis Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Bronchiectasis Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Bronchiectasis Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Bronchiectasis Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Endo International Plc
- GlaxoSmithKline Plc
- Neopharma LLC
- Pfizer Inc.
- Reckitt Benckiser Group Plc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Bronchiectasis Drugs, market overview.
Chapter 2: Global Bronchiectasis Drugs market size in revenue.
Chapter 3: Detailed analysis of Bronchiectasis Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bronchiectasis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Bronchiectasis Drugs Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Bronchiectasis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bronchiectasis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bronchiectasis Drugs Overall Market Size
2.1 Global Bronchiectasis Drugs Market Size: 2022 VS 2030
2.2 Global Bronchiectasis Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Bronchiectasis Drugs Players in Global Market
3.2 Top Global Bronchiectasis Drugs Companies Ranked by Revenue
3.3 Global Bronchiectasis Drugs Revenue by Companies
3.4 Top 3 and Top 5 Bronchiectasis Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Bronchiectasis Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bronchiectasis Drugs Players in Global Market
3.6.1 List of Global Tier 1 Bronchiectasis Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Bronchiectasis Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Bronchiectasis Drugs Market Size Markets, 2022 & 2030
4.1.2 Antibiotics
4.1.3 Expectorants
4.1.4 Other drugs
4.2 By Type - Global Bronchiectasis Drugs Revenue & Forecasts
4.2.1 By Type - Global Bronchiectasis Drugs Revenue, 2018-2023
4.2.2 By Type - Global Bronchiectasis Drugs Revenue, 2024-2030
4.2.3 By Type - Global Bronchiectasis Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Bronchiectasis Drugs Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Research institute
5.1.4 Clinic
5.1.5 Other
5.2 By Application - Global Bronchiectasis Drugs Revenue & Forecasts
5.2.1 By Application - Global Bronchiectasis Drugs Revenue, 2018-2023
5.2.2 By Application - Global Bronchiectasis Drugs Revenue, 2024-2030
5.2.3 By Application - Global Bronchiectasis Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Bronchiectasis Drugs Market Size, 2022 & 2030
6.2 By Region - Global Bronchiectasis Drugs Revenue & Forecasts
6.2.1 By Region - Global Bronchiectasis Drugs Revenue, 2018-2023
6.2.2 By Region - Global Bronchiectasis Drugs Revenue, 2024-2030
6.2.3 By Region - Global Bronchiectasis Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Bronchiectasis Drugs Revenue, 2018-2030
6.3.2 US Bronchiectasis Drugs Market Size, 2018-2030
6.3.3 Canada Bronchiectasis Drugs Market Size, 2018-2030
6.3.4 Mexico Bronchiectasis Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Bronchiectasis Drugs Revenue, 2018-2030
6.4.2 Germany Bronchiectasis Drugs Market Size, 2018-2030
6.4.3 France Bronchiectasis Drugs Market Size, 2018-2030
6.4.4 U.K. Bronchiectasis Drugs Market Size, 2018-2030
6.4.5 Italy Bronchiectasis Drugs Market Size, 2018-2030
6.4.6 Russia Bronchiectasis Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Bronchiectasis Drugs Market Size, 2018-2030
6.4.8 Benelux Bronchiectasis Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Bronchiectasis Drugs Revenue, 2018-2030
6.5.2 China Bronchiectasis Drugs Market Size, 2018-2030
6.5.3 Japan Bronchiectasis Drugs Market Size, 2018-2030
6.5.4 South Korea Bronchiectasis Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Bronchiectasis Drugs Market Size, 2018-2030
6.5.6 India Bronchiectasis Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Bronchiectasis Drugs Revenue, 2018-2030
6.6.2 Brazil Bronchiectasis Drugs Market Size, 2018-2030
6.6.3 Argentina Bronchiectasis Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Bronchiectasis Drugs Revenue, 2018-2030
6.7.2 Turkey Bronchiectasis Drugs Market Size, 2018-2030
6.7.3 Israel Bronchiectasis Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Bronchiectasis Drugs Market Size, 2018-2030
6.7.5 UAE Bronchiectasis Drugs Market Size, 2018-2030
7 Bronchiectasis Drugs Companies Profiles
7.1 Endo International Plc
7.1.1 Endo International Plc Company Summary
7.1.2 Endo International Plc Business Overview
7.1.3 Endo International Plc Bronchiectasis Drugs Major Product Offerings
7.1.4 Endo International Plc Bronchiectasis Drugs Revenue in Global Market (2018-2023)
7.1.5 Endo International Plc Key News & Latest Developments
7.2 GlaxoSmithKline Plc
7.2.1 GlaxoSmithKline Plc Company Summary
7.2.2 GlaxoSmithKline Plc Business Overview
7.2.3 GlaxoSmithKline Plc Bronchiectasis Drugs Major Product Offerings
7.2.4 GlaxoSmithKline Plc Bronchiectasis Drugs Revenue in Global Market (2018-2023)
7.2.5 GlaxoSmithKline Plc Key News & Latest Developments
7.3 Neopharma LLC
7.3.1 Neopharma LLC Company Summary
7.3.2 Neopharma LLC Business Overview
7.3.3 Neopharma LLC Bronchiectasis Drugs Major Product Offerings
7.3.4 Neopharma LLC Bronchiectasis Drugs Revenue in Global Market (2018-2023)
7.3.5 Neopharma LLC Key News & Latest Developments
7.4 Pfizer Inc.
7.4.1 Pfizer Inc. Company Summary
7.4.2 Pfizer Inc. Business Overview
7.4.3 Pfizer Inc. Bronchiectasis Drugs Major Product Offerings
7.4.4 Pfizer Inc. Bronchiectasis Drugs Revenue in Global Market (2018-2023)
7.4.5 Pfizer Inc. Key News & Latest Developments
7.5 Reckitt Benckiser Group Plc
7.5.1 Reckitt Benckiser Group Plc Company Summary
7.5.2 Reckitt Benckiser Group Plc Business Overview
7.5.3 Reckitt Benckiser Group Plc Bronchiectasis Drugs Major Product Offerings
7.5.4 Reckitt Benckiser Group Plc Bronchiectasis Drugs Revenue in Global Market (2018-2023)
7.5.5 Reckitt Benckiser Group Plc Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Bronchiectasis Drugs Market Opportunities & Trends in Global Market
Table 2. Bronchiectasis Drugs Market Drivers in Global Market
Table 3. Bronchiectasis Drugs Market Restraints in Global Market
Table 4. Key Players of Bronchiectasis Drugs in Global Market
Table 5. Top Bronchiectasis Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Bronchiectasis Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Bronchiectasis Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Bronchiectasis Drugs Product Type
Table 9. List of Global Tier 1 Bronchiectasis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bronchiectasis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Bronchiectasis Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Bronchiectasis Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Bronchiectasis Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Bronchiectasis Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Bronchiectasis Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Bronchiectasis Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Bronchiectasis Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Bronchiectasis Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Bronchiectasis Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Bronchiectasis Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Bronchiectasis Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Bronchiectasis Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Bronchiectasis Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Bronchiectasis Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Endo International Plc Company Summary
Table 31. Endo International Plc Bronchiectasis Drugs Product Offerings
Table 32. Endo International Plc Bronchiectasis Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Endo International Plc Key News & Latest Developments
Table 34. GlaxoSmithKline Plc Company Summary
Table 35. GlaxoSmithKline Plc Bronchiectasis Drugs Product Offerings
Table 36. GlaxoSmithKline Plc Bronchiectasis Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. GlaxoSmithKline Plc Key News & Latest Developments
Table 38. Neopharma LLC Company Summary
Table 39. Neopharma LLC Bronchiectasis Drugs Product Offerings
Table 40. Neopharma LLC Bronchiectasis Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Neopharma LLC Key News & Latest Developments
Table 42. Pfizer Inc. Company Summary
Table 43. Pfizer Inc. Bronchiectasis Drugs Product Offerings
Table 44. Pfizer Inc. Bronchiectasis Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Pfizer Inc. Key News & Latest Developments
Table 46. Reckitt Benckiser Group Plc Company Summary
Table 47. Reckitt Benckiser Group Plc Bronchiectasis Drugs Product Offerings
Table 48. Reckitt Benckiser Group Plc Bronchiectasis Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Reckitt Benckiser Group Plc Key News & Latest Developments
List of Figures
Figure 1. Bronchiectasis Drugs Segment by Type in 2022
Figure 2. Bronchiectasis Drugs Segment by Application in 2022
Figure 3. Global Bronchiectasis Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Bronchiectasis Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Bronchiectasis Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Bronchiectasis Drugs Revenue in 2022
Figure 8. By Type - Global Bronchiectasis Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Bronchiectasis Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Bronchiectasis Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Bronchiectasis Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Bronchiectasis Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Bronchiectasis Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Bronchiectasis Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Bronchiectasis Drugs Revenue Market Share, 2018-2030
Figure 16. US Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Bronchiectasis Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Bronchiectasis Drugs Revenue Market Share, 2018-2030
Figure 28. China Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Bronchiectasis Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Bronchiectasis Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Bronchiectasis Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Endo International Plc Bronchiectasis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. GlaxoSmithKline Plc Bronchiectasis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Neopharma LLC Bronchiectasis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pfizer Inc. Bronchiectasis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Reckitt Benckiser Group Plc Bronchiectasis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
